{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-079653","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2024-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.043956+00:00","generated_at":"2026-06-01T00:03:59.802816+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aptevo raises ~$2.75M gross in registered direct offering at $0.515/share","bullets":["Offering of 5,339,806 shares (or pre-funded warrants) and 10,679,612 common warrants at $0.515/share; net proceeds ~$2.3M.","Common warrants exercisable at $0.515/share upon stockholder approval, expire 5 years later.","Existing warrants from Aug 2023, Nov 2023, Apr 2024 amended to $0.515 exercise price, also subject to stockholder approval.","Proceeds for clinical development of product candidates and working capital.","Roth Capital Partners placement agent; closing July 1, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-079653","json":"https://secwatch.observer/filing/0000950170-24-079653.json","markdown":"https://secwatch.observer/filing/0000950170-24-079653.md","text":"https://secwatch.observer/filing/0000950170-24-079653.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024079653/0000950170-24-079653-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024079653/apvo-20240628.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:03:59.802816+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}